Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02328937 · ClinicalTrials.gov registry record · NA
Central Corneal Swelling With Silicone Hydrogel Materials
A NA study of Corneal Swelling, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT02328937: Completed NA study of Corneal Swelling, sponsored by Johnson & Johnson Vision Care.
NCT02328937 is a NA study of Corneal Swelling that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02328937, a NA study of Corneal Swelling, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, single site, unmasked, cross-over study with three silicone hydrogel contact lenses comparing central corneal swelling.
Primary Outcome
Corneal swelling measurements were taken in the right eye during slit lamp evaluations, 6-8 hours post lens insertion. The average corneal swelling per lens was reported.
Conditions Studied
Interventions
- DEVICE lotrafilcon B
- DEVICE etafilcon A
- DEVICE comfilcon A
Study Locations (1)
Ohio
- - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT02328937 record still lists
NCT02328937 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Corneal Swelling appearing as the primary indexed condition, and to 3 interventions - of which lotrafilcon B is the first listed.
NCT02328937 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02328937 about?
NCT02328937 is a clinical study titled "Central Corneal Swelling With Silicone Hydrogel Materials". This is a prospective, single site, unmasked, cross-over study with three silicone hydrogel contact lenses comparing central corneal swelling.
What is the current status of trial NCT02328937?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2014-11. Estimated completion is 2015-04.
What conditions does trial NCT02328937 study?
This clinical trial studies the following conditions: Corneal Swelling.
What interventions are being tested in trial NCT02328937?
The interventions under investigation include: lotrafilcon B (DEVICE), etafilcon A (DEVICE), comfilcon A (DEVICE).
Who is sponsoring clinical trial NCT02328937?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02328937 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02328937's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia